Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More

Chromadex Corp CS (CDXC)

Chromadex Corp CS (CDXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Chromadex Corp CS 10900 Wilshire Blvd. Suite 650 Los Angeles CA 90024 USA

P: 310-388-6706


ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is to use the intellectual property harnessed by its expertise in the area of natural products and in the creation of reference materials to the industry as the basis for providing new and alternative, `green`, mass marketable products to its customers. The Company's main priority is to create industry-accepted information, and to provide products and services to every layer of the functional food, pharmaceutical, personal care and dietary supplement markets. The company markets and sells its products in the United States and Canada. It offers its products through distributors in Europe, South America, Korea, India, Japan, Australia, New Zealand, China, Indonesia, Malaysia, Singapore, Thailand, and Mexico.

Key Statistics


Market Capitalization, $K 198,355
Shares Outstanding, K 59,566
Annual Sales, $ 31,560 K
Annual Net Income, $ -33,320 K
Last Quarter Sales, $ 11,100 K
Last Quarter Net Income, $ -7,760 K
60-Month Beta 1.38
% of Insider Shareholders 10.26%
% of Institutional Shareholders 18.48%
Float, K 53,455
% Float 89.74%


1-Year Return -11.20%
3-Year Return 15.62%
5-Year Return 19.35%
5-Year Revenue Growth 210.63%
5-Year Earnings Growth -408.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/06/19
Earnings Per Share ttm -0.60
EPS Growth vs. Prev Qtr 6.67%
EPS Growth vs. Prev Year 6.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-3 on 04/13/16

CDXC Ratios

Price/Earnings ttm 0.00
Price/Earnings forward -7.81
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -136.15
Return-on-Assets (Before Tax) -74.93
Profit Margin % -105.58
Net Margin % -59.24
Debt/Equity 0.09
Price/Sales 6.40
Price/Cash Flow N/A
Price/Book 12.43
Book Value/Share 0.27
Interest Coverage -415.50
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar